Skip to content

Artiva Biotherapeutics, Inc. ARTV Return on invested capital

Return on invested capital at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
13%+4.2pp
Gilead Sciences logo
Gilead SciencesGILD
23.7%+4.4pp
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
-94.5%-4.6pp
Allogene Therapeutics logo
Allogene TherapeuticsALLO
-51.3%-5.7pp
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-58%+22.6pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-35.4%-12.2pp

Other financials

Income statement

See full
Revenue-
Operating income-$24.4M-10.2%
Net income-$23.5M-15.8%
EPS (diluted)-$0.95-14.5%

Balance sheet

See full
Cash & equivalents$21.4M-30.6%
Total debt$10.3M-26.7%
Total equity$87.8M-48.0%
Total assets$106.0M-44.6%

Cash flow

See full
Operating cash flow-$21.0M-5.6%
CapEx$242.0K-52.6%
Free cash flow-$21.2M-4.1%

Valuation

See full
Market cap$429.03M+1,015%
Enterprise value$417.88M+1,832%

Profitability

See full
Operating margin-83.9%
Net margin-79.3%

Returns & leverage

See full
Return on equity-67.9%
Debt / equity0.1×0.0×
Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s return on invested capital?
Artiva Biotherapeutics, Inc. (ARTV) reported return on invested capital of -80.5% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.